Cargando…

Low-Dose Immunotherapy: Is It Just an Illusion?

The development and use of immunotherapy in the last decade have led to a drastic improvement in results in the onco-haematological field. This has implied, on the one hand, the need for clinicians to manage a new type of adverse event and, on the other hand, a significant increase in costs. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Meriggi, Fausto, Zaniboni, Alberto, Zaltieri, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136204/
https://www.ncbi.nlm.nih.gov/pubmed/37189650
http://dx.doi.org/10.3390/biomedicines11041032